التفاصيل البيبلوغرافية
| العنوان: |
Differential Contributions of Actin and Myosin to the Physical Phenotypes and Invasion of Pancreatic Cancer Cells. |
| المؤلفون: |
Nguyen, Angelyn V., Trompetto, Brittany, Tan, Xing Haw Marvin, Scott, Michael B., Hu, Kenneth Hsueh-heng, Deeds, Eric, Butte, Manish J., Chiou, Pei Yu, Rowat, Amy C. |
| المصدر: |
Cellular & Molecular Bioengineering; Feb2020, Vol. 13 Issue 1, p27-44, 18p |
| مصطلحات موضوعية: |
MYOSIN, CANCER cells, PANCREATIC cancer, ATOMIC force microscopy, ACTIN, FORMINS |
| مستخلص: |
Introduction: Metastasis is a fundamentally physical process in which cells deform through narrow gaps and generate forces to invade surrounding tissues. While it is commonly thought that increased cell deformability is an advantage for invading cells, we previously found that more invasive pancreatic ductal adenocarcinoma (PDAC) cells are stiffer than less invasive PDAC cells. Here we investigate potential mechanisms of the simultaneous increase in PDAC cell stiffness and invasion, focusing on the contributions of myosin II, Arp2/3, and formins. Method: We measure cell invasion using a 3D scratch wound invasion assay and cell stiffness using atomic force microscopy (AFM). To determine the effects of actin- and myosin-mediated force generation on cell stiffness and invasion, we treat cells with pharmacologic inhibitors of myosin II (blebbistatin), Arp2/3 (CK-666), and formins (SMIFH2). Results: We find that the activity of myosin II, Arp2/3, and formins all contribute to the stiffness of PDAC cells. Interestingly, we find that the invasion of PDAC cell lines is differentially affected when the activity of myosin II, Arp2/3, or formins is inhibited, suggesting that despite having similar tissue origins, different PDAC cell lines may rely on different mechanisms for invasion. Conclusions: These findings deepen our knowledge of the factors that regulate cancer cell mechanotype and invasion, and incite further studies to develop therapeutics that target multiple mechanisms of invasion for improved clinical benefit. [ABSTRACT FROM AUTHOR] |
|
Copyright of Cellular & Molecular Bioengineering is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Find this article in full text from Springer Verlag. 
Full Text Finder